Drug notes:
CRD-4730 Clin1 catecholaminergic polymorphic ventricular tachycardia; undisclosed Clin0 heart failure; 2 undisclosed programs RD atrial fibrillation, cardiovascular disease
About:
Cardurion Pharmaceuticals is a next-generation cardiovascular biotech company founded by Dr. Michael E. Mendelsohn, a physician-Scientist with over 150 published articles. They focus on therapeutics that target cardiac myocyte signaling pathways to treat heart failure and other cardiovascular diseases. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan.
Jobs:
Associate Director, Clinical Science Massachusetts, United States|11 days ago
Sr. ClinPharm Clinical Trial Manager Massachusetts, United States|17 days ago
Clinical Trial Manager / Sr. Clinical Trial Manage... Burlington, MA|82 days ago
Director, Clinical Quality Assurance Burlington, MA|100+ days ago
Accounting Manager Burlington, VT|Not provided